NON RARE IN EUROPE: Lipedema

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:77243OMIM:614103
Who is this for?
Show terms as
View depth
2Active trials8Treatment centers

Where are you in your journey?

UniteRare data is compiled from authoritative primary sources (FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, NORD), then processed through automated and AI-assisted extraction pipelines.
Report missing data

What is NON RARE IN EUROPE: Lipedema?

Lipedema (also spelled lipoedema, and sometimes called 'painful fat syndrome') is a chronic condition where abnormal amounts of fat build up under the skin, almost always in the legs, hips, and buttocks, and sometimes in the arms. It affects mostly women and people assigned female at birth. Unlike regular weight gain, this fat is distributed in a very specific, symmetrical pattern — both legs are affected equally — and it does not respond well to diet or exercise. The fat tissue in lipedema is different from normal fat: it tends to be painful or tender to the touch, feels soft and spongy, and bruises easily. Lipedema usually starts or gets worse during hormonal changes, such as puberty, pregnancy, or menopause. Over time, the condition can progress and may lead to problems with movement and joint pain. Many people with lipedema also develop lymphedema (swelling caused by a damaged lymph system), a combination sometimes called lipo-lymphedema. There is no cure for lipedema, but several treatments can help manage symptoms and slow progression. These include a type of gentle massage called manual lymphatic drainage (MLD), compression garments, a low-inflammation diet, regular low-impact exercise (like swimming or cycling), and in some cases, a specialized surgical procedure called liposuction (water-jet assisted or tumescent liposuction). Early diagnosis and treatment are important to prevent the condition from getting worse.

Key symptoms:

Symmetrical fat buildup in both legs, hips, and buttocks that does not match the rest of the bodyPain or tenderness in the affected areas, even with light touchEasy bruising in the legs and armsSkin that feels soft, spongy, or lumpy under the surfaceSwelling that gets worse throughout the day or in warm weatherFeeling of heaviness or tightness in the legsFat that does not shrink with diet or exerciseA clear difference between the size of the waist and the legsFeet are usually not affected (the fat stops at the ankle, creating a 'cuff' appearance)Emotional distress, low self-esteem, or depression related to body changesDifficulty walking or reduced mobility as the condition progressesJoint pain, especially in the knees and hipsSwelling in the lower legs that may indicate lymphedema developing alongside lipedema

Inheritance
Multifactorial
Caused by a mix of several genes and environmental factors
Age of Onset
Variable
Can begin at different ages, from infancy through adulthood
Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

2 events
Jan 2026Investigation of Medial Longitudinal Arch and Foot Function in Patients With Lipedema

Marmara University

TrialRECRUITING
Apr 2022Adipose Cellular Kinetics of Lipedema

Pennington Biomedical Research Center

TrialRECRUITING

Data is compiled from FDA regulatory filings and ClinicalTrials.gov, then processed through automated extraction; event classifications and dates may occasionally be misclassified. Verify against the linked FDA filing or trial record before clinical decisions. Updated periodically.

Treatments

Source: openFDA + DailyMed · NDA / BLA labels with structured indications · refreshed weekly

No FDA-approved treatments are currently listed for NON RARE IN EUROPE: Lipedema.

2 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

2 recruitingView all trials with filters →

Source: ClinicalTrials.gov · synced daily · phases, status, and PI names normalized at ingest

Other2 trials
Adipose Cellular Kinetics of Lipedema
Actively Recruiting
· Sites: Baton Rouge, Louisiana · Age: 18–45 yrs
Investigation of Medial Longitudinal Arch and Foot Function in Patients With Lipedema
Actively Recruiting
· Sites: Istanbul · Age: 18–65 yrs

Source: NPI Registry + PubMed · trial PI roles cross-referenced with ClinicalTrials.gov · ranked by match score (publications + PI activity + community signal)

No specialists are currently listed for NON RARE IN EUROPE: Lipedema.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers

Source: NORD Rare Disease Centers + NIH Undiagnosed Diseases Network (UDN) · centers verified active within last 12 months

🏨 Children's

Children's Hospital Colorado Rare Disease Program

Children's Hospital Colorado

📍 Aurora, CO

👤 Boston Children's Hospital Rare Disease Program

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Boston Children's Hospital Rare Disease Program

Boston Children's Hospital

📍 Boston, MA

👤 Boston Children's Hospital Rare Disease Program

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

🏨 Children's

Ann & Robert H. Lurie Children's Hospital Genetics

Lurie Children's Hospital

📍 Chicago, IL

👤 Boston Children's Hospital Rare Disease Program

🏥 NORD

Cincinnati Children's Hospital Medical Center

Cincinnati Children's

📍 Cincinnati, OH

👤 Boston Children's Hospital Rare Disease Program

🏨 Children's

Nationwide Children's Hospital Rare Disease Center

Nationwide Children's Hospital

📍 Columbus, OH

👤 Boston Children's Hospital Rare Disease Program

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

Travel Grants

No travel grants are currently matched to NON RARE IN EUROPE: Lipedema.

Search all travel grants →NORD Financial Assistance ↗

Community

Open NON RARE IN EUROPE: LipedemaForum →

No community posts yet. Be the first to share your experience with NON RARE IN EUROPE: Lipedema.

Start the conversation →

Latest news about NON RARE IN EUROPE: Lipedema

Source: PubMed + NIH RePORTER + openFDA + clinical-journal RSS · last 30 days · disease-tagged at ingest by AI extraction with human QC

No recent news articles for NON RARE IN EUROPE: Lipedema.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What stage of lipedema do I have, and what does that mean for my treatment options?,Should I see a lymphedema therapist, and how often would I need manual lymphatic drainage?,Am I a candidate for specialized liposuction, and what results could I realistically expect?,What type of compression garments do I need, and how do I get properly fitted?,Are there dietary changes that could help slow the progression of my lipedema?,Could my family members be at risk, and should they be evaluated?,What signs should I watch for that would mean my condition is getting worse or that I need urgent care?

Common questions about NON RARE IN EUROPE: Lipedema

What is NON RARE IN EUROPE: Lipedema?

Lipedema (also spelled lipoedema, and sometimes called 'painful fat syndrome') is a chronic condition where abnormal amounts of fat build up under the skin, almost always in the legs, hips, and buttocks, and sometimes in the arms. It affects mostly women and people assigned female at birth. Unlike regular weight gain, this fat is distributed in a very specific, symmetrical pattern — both legs are affected equally — and it does not respond well to diet or exercise. The fat tissue in lipedema is different from normal fat: it tends to be painful or tender to the touch, feels soft and spongy, and

How is NON RARE IN EUROPE: Lipedema inherited?

NON RARE IN EUROPE: Lipedema follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

Are there clinical trials for NON RARE IN EUROPE: Lipedema?

Yes — 2 recruiting clinical trials are currently listed for NON RARE IN EUROPE: Lipedema on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Explore related conditions

Conditions related to NON RARE IN EUROPE: Lipedema

Other rare diseases that share clinical features, genetic basis, or diagnostic-code family with NON RARE IN EUROPE: Lipedema. These are starting points for further reading, not a substitute for a clinician's assessment.

Frequently asked questions about NON RARE IN EUROPE: Lipedema

Auto-generated from canonical disease facts (Orphanet, OMIM, ClinicalTrials.gov, openFDA, NPPES). Not a substitute for clinical guidance.

  1. What is NON RARE IN EUROPE: Lipedema?

    NON RARE IN EUROPE: Lipedema is a rare disease catalogued in international rare-disease ontologies (Orphanet ORPHA:77243, OMIM 614103). It is typically inherited as multifactorial. Age of onset is generally variable. For verified primary sources, see the UniteRare NON RARE IN EUROPE: Lipedema page.

  2. How is NON RARE IN EUROPE: Lipedema inherited?

    NON RARE IN EUROPE: Lipedema follows multifactorial inheritance. Genetic counseling is recommended for affected families to understand recurrence risk in offspring and the likelihood of unaffected siblings being carriers. Variants in the underlying gene(s) may be identified via clinical genetic testing.

  3. Are there FDA-approved treatments for NON RARE IN EUROPE: Lipedema?

    Approved treatments for NON RARE IN EUROPE: Lipedema are tracked from openFDA and DailyMed primary sources. Many rare diseases have no specific FDA-approved therapy; for those, supportive care and management of complications form the basis of clinical care. Orphan-drug-designation status is noted where applicable.

  4. Are there clinical trials recruiting for NON RARE IN EUROPE: Lipedema?

    UniteRare currently lists 2 clinical trials relevant to NON RARE IN EUROPE: Lipedema sourced from ClinicalTrials.gov. Each trial entry includes recruitment status, eligibility criteria summary, principal-investigator information, and study locations. Patients should discuss eligibility with their healthcare provider before enrolling.

  5. How do I find a specialist for NON RARE IN EUROPE: Lipedema?

    Verified NON RARE IN EUROPE: Lipedema specialists are identified through ClinicalTrials.gov principal-investigator records, peer-reviewed publication authorship (via PubMed), and the NPPES NPI registry. NORD-designated Centers of Excellence and NIH-affiliated rare-disease clinics are also tracked. UniteRare's specialist directory is updated continuously as new evidence becomes available.

See full NON RARE IN EUROPE: Lipedema page for complete clinical details, sources, and verified-specialist listings.

Cite this page

Select a citation format above to view and copy.